Integer Holdings Stock-Based Compensation 2010-2025 | ITGR
Integer Holdings stock-based compensation from 2010 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
| Integer Holdings Annual Stock-Based Compensation (Millions of US $) |
|
|---|---|
| 2024 | $25 |
| 2023 | $23 |
| 2022 | $21 |
| 2021 | $16 |
| 2020 | $9 |
| 2019 | $9 |
| 2018 | $10 |
| 2017 | $15 |
| 2016 | $8 |
| 2015 | $9 |
| 2014 | $13 |
| 2013 | $14 |
| 2012 | $11 |
| 2011 | $12 |
| 2010 | $7 |
| 2009 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $4.382B | $1.717B |
| Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation. | |||